Institutional investors purchased a net $571.6 thousand shares of NEOG during the quarter ended February 2013, and now own 82.24% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
| Individual stakeholders | 7.52% |
| Other institutional | 52.52% |
| Mutual fund holders | 29.72% |